NIH Teaming Up With Pharma Giants For New Treatments

The National Institute of Health announced Thursday that three pharmaceutical companies will be granting them access to industry compounds in an attempt to help the Institute spearhead new research into treatments for a wide variety of conditions.

“Americans are eagerly awaiting the next generation of cures and treatments to help them live longer and healthier lives,” Health and Human ServiceTo accelerate our nation’s therapeutic development process, it is essential that we forge strong, innovative, and strategic partnerships across government, academia and industry.”

The companies include AstraZeneca, Lilly and Pfizer and the NIH says that additional companies may eventually sign on. The compounds will be supplied to the NIH’s newly formed Natonal Center for Advancing Translational Sciences.

Tags: , , ,

About TRNS Washington Desk

View all posts by TRNS Washington Desk
TRNS Washington Desk
News updates from on and around Capitol Hill.

Click here for: Friday, April 25

● FDA seeks to expand tobacco regulations

● U.S. Constitution on trial

● The benefits of child immunization

● Shrinking youth vote

● College football unionization under review

● The medicated classroom

Deaths Reported As Ukraine Begins Offensive Against Russian Separatists

The Ukrainian armed forces cleared three road blocks near the flashpoint city of Sloviansk, according to the country’s information ministry.

Poverty Is Killing Us

It’s time to eliminate poverty in America, and give everyone a shot at living the American Dream.

Former Blue Angels Officer Under Investigation For Sexual Harassment

Former Commanding Officer of the Blue Angels, the Navy’s acrobatic fighter squadron, Capt. Gregory McWherter has since been reassigned.

Poll: Paul Leads Clinton In Swing State Colorado

Clinton also ties with New Jersey Governor Chris Christie.

Pentagon Rejects Report Of U.S. Base Overrun By Al-Qaeda

Pentagon officials claim the base was operated by Libyan personnel, not by U.S. forces in secret.